Suppression of malignant phenotype, changes in gene expression and DNA hypermethylation in human melanoma cells treated with arabinosyl cytosine.
D002460:Cell Line; D003561:Cytarabine / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000235:genetics*; D006801:Humans; D007700:Kinetics; D008545:Melanoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008745:Methylation; D009857:Oncogenes / Q000187:drug effects*; D010641:Phenotype; D014158:Transcription, Genetic / Q000187:drug effects
D004273:DNA, Neoplasm; D003561:Cytarabine